CAR T-cell therapy improves survival in relapsed or refractory lymphoma

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

What is lymphoma? 7 symptoms to watch out for

Before any major health crisis, there are symptoms that the body sends that shouldn’t be ignored. A doctor shared some such ...
CURE

CAR-T Option Expands in Primary Central Nervous System Lymphoma

Dr. Lakshmi Nayak, director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute, explained in an interview with ...
WebMD

FDA Approves Breyanzi: First and Only CAR T-Cell Therapy for Relapsed or Refractory Marginal Zone Lymphoma

What Is Breyanzi, and Why Does It Matter? Breyanzi (lisocabtagene maraleucel) is a type of personalized cancer treatment called chimeric antigen receptor (CAR) T-cell therapy, which uses your modified ...